THC vs CBD vs CBG vs CBN vs THCV: The Real Differences Explained
THC vs CBD vs CBG vs CBN vs THCV explains how each cannabinoid targets different receptors and produces distinct clinical effects. Dr. Benjamin Caplan breaks down the evidence behind pain, sleep, focus, and metabolic use cases for each compound. This…
Why CBG Topicals Are Becoming One of Hemp’s Fastest-Growing Categories | High Times
✦ New CED Clinical Relevance #68 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBGHempCBDPainIndustryResearchSafety Why This Matters Clinicians should understand that CBG (cannabigerol) topicals…
The Cannabis Component CBG Shows Promise In Treating Rheumatoid Arthritis With Its …
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchHempCBGPainRheumatoid ArthritisSafetyPharmaceuticals Clinical Summary # Clinical Summary Cannabigerol (CBG),…
Study: Minor Cannabinoids Show Distinct Effects on Pain-Sensing Neurons
Minor cannabinoids pain management research highlights their distinct effects on pain-sensing neurons. These compounds may offer new therapeutic options beyond THC and CBD. Understanding their role is crucial for advancing cannabinoid therapies.
New research suggests cannabinoids like CBD and CBG may help improve fatty liver disease.
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic NewResearchSuggestsCannabinoids Why This…
CED Digest: 35 Items — April 09, 2026
Alabama medical cannabis sales are gearing up for a spring 2026 launch, impacting clinical recommendations. Cannabis compounds CBD and CBG show promise for fatty liver disease treatment. Regulatory enforcement challenges in cannabis beverages also affect…
New Study Highlights Potential of Non-Intoxicating Cannabis Compounds CBD and CBG
This article reviews a new study on non-intoxicating cannabis compounds, focusing on CBD and CBG. The research highlights clinical relevance but lacks full methodological details. Clinicians should await peer-reviewed evidence before applying findings.
Two compounds found in surprising substance reverse liver disease damage, study suggests
This study highlights hepatoprotective effects cannabinoids may have in liver disease models. Early preclinical evidence suggests cannabinoids like CBD and CBG could reduce liver inflammation and improve metabolism. These hepatoprotective effects…
CBG vs CBD: 7 Essential Differences You Need to Know – Social Cannabis
This minor cannabinoids therapeutic potential review highlights key differences between CBG and CBD. Understanding these compounds helps clinicians guide patients effectively. Evidence-based patient education is essential for safe cannabis use.
Avicanna Subsidiary Achieves First Commercial Export of CBG Cultivar to Australia
Minor cannabinoids clinical research is advancing with Avicanna's subsidiary completing the first commercial export of a CBG-dominant cultivar to Australia. CBG offers distinct therapeutic potential compared to THC and CBD. This milestone marks growing…